Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation

Leukemia. 2013 Sep;27(9):1910-3. doi: 10.1038/leu.2013.64. Epub 2013 Mar 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use
  • Azacitidine / therapeutic use*
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Leukemia, Myeloid, Acute / blood*
  • Leukemia, Myeloid, Acute / drug therapy*
  • Lymphocyte Count*
  • Myelodysplastic Syndromes / blood*
  • Myelodysplastic Syndromes / drug therapy*
  • Recurrence
  • Salvage Therapy
  • T-Lymphocytes, Regulatory*
  • Transplantation, Homologous

Substances

  • Antimetabolites, Antineoplastic
  • Azacitidine